The Discounted Cash Flow (DCF) valuation of Travere Therapeutics Inc (TVTX) is (129.57) USD. With the latest stock price at 17.32 USD, the upside of Travere Therapeutics Inc based on DCF is -848.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 9.2% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (286.96) - (86.65) | (129.57) |
| Upside | -1756.8% - -600.3% | -848.1% |